Explore 3 Stock Ideas & Industry Insights Download Free Report
Smith+Nephew plc (LSE:SN, NYSE:SNN)reported growth for the first quarter ended 29 March 2025, driven by operational improvements and new product launches, despite external challenges including continued headwinds from China and one fewer trading day compared to the prior year.
Shares in AstraZeneca PLC (LSE:AZN) dropped by 4% in early London trading following the release of its first-quarter 2025 results, as a slight miss on revenue forecasts overshadowed stronger-than-expected earnings and a standout performance in its oncology segment.
Reckitt Benckiser Group PLC reported a resilient performance in the first quarter of 2025, with like-for-like (LFL) net revenue for Core Reckitt increasing by 3.1%. This growth was primarily fuelled by a performance from its Powerbrands, notably Germ Protection (up 7.5%) and Intimate Wellness …
GSK plc (LSE/NYSE: GSK) has received a significant step forward in the U.S. vaccination landscape, as the CDC's Advisory Committee on Immunization Practices (ACIP) voted to recommend the use of Penmenvy, a combined meningococcal vaccine. Penmenvy, which protects against meningococcal groups A, B, C, …
Assura plc (LSE:AGR), a prominent healthcare infrastructure investor and developer in the UK and Ireland, has agreed to a recommended cash acquisition by Sana Bidco Limited, in a deal that values the company at approximately £1.61 billion on a fully diluted basis.
ANGLE plc (AIM:AGL OTCQX:ANPCY), a leading liquid biopsy company known for its innovative circulating tumor cell (CTC) solutions, has announced the successful completion of its development work for two significant assays with global pharmaceutical companies AstraZeneca and Eisai. ANGLE has now completed the development …
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…